[{"address1": "30 Technology Drive", "city": "Warren", "state": "NJ", "zip": "07059", "country": "United States", "phone": "908 941 1900", "website": "https://www.aquestive.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.", "fullTimeEmployees": 142, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel  Barber", "age": 48, "title": "CEO, President & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 1097468, "exercisedValue": 0, "unexercisedValue": 469825}, {"maxAge": 1, "name": "Ms. Sherry  Korczynski", "age": 54, "title": "Senior Vice President of Sales & Marketing", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter E. Boyd", "age": 58, "title": "Senior Vice President of Information Technology & Human Resources", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary H. Slatko M.D., MBA", "age": 67, "title": "Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Carl N. Kraus M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 5, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.0, "open": 3.01, "dayLow": 2.945, "dayHigh": 3.049, "regularMarketPreviousClose": 3.0, "regularMarketOpen": 3.01, "regularMarketDayLow": 2.945, "regularMarketDayHigh": 3.049, "payoutRatio": 0.0, "beta": 2.591, "forwardPE": -5.0, "volume": 718501, "regularMarketVolume": 718501, "averageVolume": 1560733, "averageVolume10days": 1014740, "averageDailyVolume10Day": 1014740, "bid": 2.94, "ask": 3.09, "bidSize": 10, "askSize": 10, "marketCap": 296614208, "fiftyTwoWeekLow": 2.2, "fiftyTwoWeekHigh": 5.8, "priceToSalesTrailing12Months": 5.1530414, "fiftyDayAverage": 2.8049, "twoHundredDayAverage": 3.79995, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 263072112, "profitMargins": -0.76679003, "floatShares": 94253087, "sharesOutstanding": 98871400, "sharesShort": 9870823, "sharesShortPriorMonth": 10228131, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0998, "heldPercentInsiders": 0.050219998, "heldPercentInstitutions": 0.48483002, "shortRatio": 7.1, "shortPercentOfFloat": 0.1177, "impliedSharesOutstanding": 99570096, "bookValue": -0.658, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -44137000, "trailingEps": -0.51, "forwardEps": -0.6, "enterpriseToRevenue": 4.57, "enterpriseToEbitda": -8.76, "52WeekChange": -0.14285713, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 3.0, "targetHighPrice": 15.0, "targetLowPrice": 4.75, "targetMeanPrice": 9.86111, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 9, "totalCash": 71546000, "totalCashPerShare": 0.724, "ebitda": -30030000, "totalDebt": 38004000, "quickRatio": 4.182, "currentRatio": 4.676, "totalRevenue": 57561000, "revenuePerShare": 0.664, "returnOnAssets": -0.24215001, "grossProfits": 39689000, "freeCashflow": -10494500, "operatingCashflow": -35759000, "revenueGrowth": -0.101, "grossMargins": 0.68951, "ebitdaMargins": -0.52171004, "operatingMargins": -1.1442701, "financialCurrency": "USD", "symbol": "AQST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 0.0, "regularMarketPrice": 3.0, "shortName": "Aquestive Therapeutics, Inc.", "longName": "Aquestive Therapeutics, Inc.", "priceEpsCurrentYear": -4.6875, "fiftyDayAverageChange": 0.19510007, "fiftyDayAverageChangePercent": 0.06955687, "twoHundredDayAverageChange": -0.7999499, "twoHundredDayAverageChangePercent": -0.2105159, "priceToBook": -4.5592704, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1746221901, "regularMarketTime": 1746216001, "exchange": "NGM", "messageBoardId": "finmb_8142504", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532525400000, "fiftyTwoWeekLowChange": 0.79999995, "fiftyTwoWeekLowChangePercent": 0.36363634, "fiftyTwoWeekRange": "2.2 - 5.8", "fiftyTwoWeekHighChange": -2.8000002, "fiftyTwoWeekHighChangePercent": -0.48275864, "fiftyTwoWeekChangePercent": -14.285713, "earningsTimestamp": 1747080000, "earningsTimestampStart": 1747080000, "earningsTimestampEnd": 1747080000, "earningsCallTimestampStart": 1747137600, "earningsCallTimestampEnd": 1747137600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.51, "epsForward": -0.6, "epsCurrentYear": -0.64, "postMarketChangePercent": 1.66667, "postMarketPrice": 3.05, "postMarketChange": 0.05, "regularMarketChange": 0.0, "regularMarketDayRange": "2.945 - 3.049", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1560733, "displayName": "Aquestive Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]